Future potential research directions aim to: investigate the specific mechanisms of SHMT2 in immune-related signaling pathways in HNSCC, and its impact on therapeutic immune responses; and evaluate the clinical significance of targeting SHMT2 in HNSCC treatment and its role as a therapeutic intervention to improve patient prognosis. Here, SHMT2 is linked to head and neck squamous cell carcinoma.